Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders' Equity Up 21% Since Year-End
Key Highlights
- ➤Nine-month revenue reached record $53.59 million, up 17.6% year-over-year
- ➤Gross margin rebounded to 12.6%, up 465 basis points sequentially
- ➤Total debt fell 33.8% to $12.83 million since year-end 2025
- ➤Stockholders’ equity rose 21.2% to $22.33 million since year-end 2025
- ➤U.S. subscriptions exceeded 12,500, reaching $1.83 million monthly value by October 31
Expert Statements
Greg Siokas, CEO of Cosmos Health
“We are pleased with our progress this year. We delivered record nine-month revenue of $53.6 million, up 18%, driven by strong momentum across our core segments. And we have strengthened the balance sheet: since January we have cut total debt by a third, reduced total liabilities by 18%, grown stockholders' equity by more than 20%, cut convertible notes by more than 80% and fully settled the ATW note approximately a year ahead of maturity.”
Greg Siokas, CEO of Cosmos Health
“The third quarter also showed sequential improvement: gross margin rebounded by 465 basis points from the second quarter, Adjusted EBITDA improved by approximately 18% sequentially, and interest expense fell by more than half year-over-year.”
Greg Siokas, CEO of Cosmos Health
“What excites me most is what we are building in the United States. In roughly six weeks of scaling, our direct-to-consumer business grew to more than 12,500 active subscriptions and $1.83 million in monthly subscription value, approximately $22 million annualized. Together with a record contract manufacturing pipeline of more than 32.7 million units, entry into markets including Saudi Arabia and Oceania and new automation at CosmoFarm, we have entered the fourth quarter with strong momentum. Looking ahead, we believe Cosmos Health is well positioned for continued growth, and that the progress achieved in 2026 has established a stronger foundation for the next phase of Cosmos Health's development.”
CHICAGO, IL / ACCESS Newswire / November 18, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM),a diversified, vertically integrated global healthcare group, today reported financial results for the third quarter and nine months ended September 30, 2026, highlighted by record nine-month revenue, a strengthened balance sheet and a sequential improvement in gross margin and Adjusted EBITDA. Third Quarter and Nine-Month 2026 Financial Highlights
Revenue * Nine-month revenue reached a record $53.59 million, up $8.03 million, or 17.6%, from $45.57 million in the first nine months of 2025, driven by strong momentum across core operating segments, including pharmaceutical distribution at CosmoFarm, which added more than 75 new pharmacies to its client portfolio during the period. * Third-quarter revenue was $16.68 million, broadly in line with $17.11 million in the third quarter of 2025, and was partially impacted by revenue reversals. Sequential Improvement in Gross Margin and Adjusted EBITDA * Gross margin rebounded to 12.6% in Q3 2026, up 465 basis points from 7.96% in Q2 2026. * Adjusted EBITDA improved approximately 18% sequentially, to a loss of $0.93 million from a loss of $1.13 million in Q2 2026. Operating Discipline * Nine-month total operating expenses grew 14.1%, below revenue growth of 17.6%. * Third-quarter salaries and wages declined 10.5% year-over-year, while the Company increased sales and marketing investment to support its brands. Lower Interest Expense * Third-quarter interest expense fell 56.9% to $0.29 million, from $0.67 million in Q3 2025, as the Company reduced its debt during 2026. Net Loss Driven by Non-Cash Charges * Third-quarter net loss narrowed to $5.25 million, from $5.35 million in Q3 2025. * Approximately $3.1 million, or 59%, of the Q3 net loss consisted of net non-cash charges related primarily to the Company's convertible notes, including non-cash interest expense and changes in fair value. Balance Sheet Transformation
Get started
Create a free account to read the full story.
